°µÍø³Ô¹Ï

$65.0 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$31.2 Million
Kiadis Pharma B.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$57.9 Million
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$143.8 Million
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.0 Million
Zafgen, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$46.0 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$57.5 Million
Synlogic, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.0 Million
Adverum Biotechnologies, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$46.0 Million
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.0 Million
ImmunoVaccine (IMV, Inc.)
At the Market Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 °µÍø³Ô¹Ï. Since 1895. All rights reserved.